Compare UTHR & TYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UTHR | TYL |
|---|---|---|
| Founded | 1996 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.5B | 19.1B |
| IPO Year | 1999 | N/A |
| Metric | UTHR | TYL |
|---|---|---|
| Price | $485.36 | $348.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 13 |
| Target Price | $498.83 | ★ $616.46 |
| AVG Volume (30 Days) | 343.7K | ★ 560.6K |
| Earning Date | 02-25-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 16.08 | ★ 31.32 |
| EPS | ★ 26.38 | 7.19 |
| Revenue | ★ $3,128,400,000.00 | $2,298,292,000.00 |
| Revenue This Year | $13.57 | $10.86 |
| Revenue Next Year | $5.72 | $8.86 |
| P/E Ratio | ★ $18.16 | $47.40 |
| Revenue Growth | ★ 13.50 | 10.62 |
| 52 Week Low | $266.98 | $320.23 |
| 52 Week High | $519.99 | $661.31 |
| Indicator | UTHR | TYL |
|---|---|---|
| Relative Strength Index (RSI) | 54.06 | 22.44 |
| Support Level | $462.02 | $320.23 |
| Resistance Level | $487.50 | $355.80 |
| Average True Range (ATR) | 9.08 | 17.33 |
| MACD | 1.70 | -8.63 |
| Stochastic Oscillator | 88.42 | 17.42 |
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.
Tyler Technologies provides a full suite of software solutions and services that address the needs of cities, counties, schools, courts and other local government entities. The company's three core products are Munis, which is the core ERP system, Odyssey, which is the court management system, or CMS, and payments. The company also provides a variety of add-on modules and offers outsourced property tax assessment services.